Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Tissue-based test volumes increase by 36%, liquid-based test volumes by 24% Company raises 2024 revenue guidance to $87-89 million, representing 25% growth Pro-forma cash of $53.5 million...
MDxHealth to Present Third Quarter 2024 Financial Resultsand Corporate Update on November 6 Company to Host Conference Call with Live Q&A, November 6, 2024, at 4:30pm ET / 22:30 CET IRVINE...
MDxHealth Announces Pricing of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM – September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company“), a...
MDxHealth Announces Launch of Offering of Ordinary Shares IRVINE, CA, and HERSTAL, BELGIUM –September 25, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (“mdxhealth” or the “Company”), a...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2395 | 14.0058479532 | 1.71 | 1.9495 | 1.55 | 297712 | 1.63987667 | CS |
| 4 | -0.0505 | -2.525 | 2 | 2.25 | 1.55 | 157802 | 1.81206341 | CS |
| 12 | -0.9205 | -32.0731707317 | 2.87 | 2.9799 | 1.55 | 127172 | 1.97664256 | CS |
| 26 | -0.9105 | -31.8356643357 | 2.86 | 3.5 | 1.55 | 75953 | 2.1660183 | CS |
| 52 | -1.0105 | -34.1385135135 | 2.96 | 4.64 | 1.55 | 70879 | 2.68288305 | CS |
| 156 | -7.7505 | -79.9020618557 | 9.7 | 10.95 | 1.55 | 75273 | 3.77097308 | CS |
| 260 | -10.2005 | -83.9547325103 | 12.15 | 13.17 | 1.55 | 75641 | 3.93193865 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
